HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Salvador Rassi Selected Research
Salvador Rassi Research Topics
Disease
10
Heart Failure
12/2018 - 02/2007
4
Chagas Disease (American Trypanosomiasis)
01/2019 - 02/2017
4
Heart Diseases (Heart Disease)
12/2018 - 11/2011
2
Hypotension (Low Blood Pressure)
01/2018 - 04/2005
2
Chagas Cardiomyopathy
05/2014 - 05/2012
2
Anemia
10/2013 - 02/2007
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1
Atrioventricular Block
01/2018
1
Bradycardia
01/2018
1
Syncope (Fainting)
01/2018
1
Ventricular Tachycardia
03/2017
1
Type 2 Diabetes Mellitus (MODY)
02/2016
1
Ventricular Dysfunction
08/2015
1
Breast Neoplasms (Breast Cancer)
02/2014
1
Cardiotoxicity
02/2014
1
Cardiomyopathies (Cardiomyopathy)
05/2012
1
Tachycardia (Tachyarrhythmias)
04/2005
Drug/Important Bio-Agent (IBA)
2
Dobutamine
FDA Link
Generic
01/2019 - 02/2017
2
Creatinine
IBA
03/2017 - 04/2005
2
Iron
IBA
10/2013 - 02/2007
2
Erythropoietin
FDA Link
10/2013 - 02/2007
1
Atropine
FDA Link
Generic
01/2019
1
sacubitril and valsartan sodium hydrate drug combination
IBA
12/2018
1
Ivabradine
IBA
01/2018
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
10/2017
1
Biomarkers (Surrogate Marker)
IBA
10/2017
1
Sodium
IBA
03/2017
1
Human Isophane Insulin
FDA Link
02/2016
1
Insulin (Novolin)
FDA Link
02/2016
1
Protamines (Protamine Sulfate)
FDA Link
02/2016
1
Human Regular Insulin (Humulin)
IBA
02/2016
1
Anthracyclines
IBA
08/2015
1
Trastuzumab (Herceptin)
FDA Link
02/2014
1
Pharmaceutical Preparations
IBA
01/2014
1
Digoxin (Digitek)
FDA Link
Generic
01/2014
1
Transferrin (beta 2 Transferrin)
IBA
10/2013
1
Ferritins (Ferritin)
IBA
10/2013
1
Creatine
IBA
07/2012
1
Simendan (Levosimendan)
IBA
03/2008
1
Adrenergic Agonists (Adrenergic Receptor Agonist)
IBA
03/2008
Therapy/Procedure
3
Cell- and Tissue-Based Therapy (Cell Therapy)
03/2014 - 11/2011
2
Therapeutics
05/2014 - 05/2012
1
Glycemic Control
02/2016
1
Transplantation
05/2012